One-third of patients with dominant MYH9-mutations, those previously classified as having Epstein's or Fetchner's Syndrome, develop glomerulosclerosis and progress to end stage kidney disease requiring dialysis or transplantation by the 2nd or 3rd decade [1], [2]. This evidence concerns the gene MYH9 and glomerulosclerosis.